GlassScriptPhysician profile
Morteza Meftah
NPI 1740463272
$124,945.76
in general payments reported to CMS, 2019-2025
20 companies · $90K in 2025
The $90K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,823 · 2020: $3,782 · 2021: $1,757 · 2022: $1,771 · 2023: $3,586 · 2024: $21K · 2025: $90K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $91K · Travel and Lodging: $15K · Food and Beverage: $5,706 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $91,132.10 |
| Travel and Lodging | $14,724.39 |
| Food and Beverage | $5,705.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $64,157.45 | 2019-2025 | Real Intelligence, Journey II, K-15 Pork |
| Medacta USA, INC. | $26,355.35 | 2021-2025 | Nextar Knee, Gmk Sphere, Amistem |
| Exactech, INC. | $19,615.77 | 2022-2025 | |
| Intellijoint Surgical INC. | $7,450.38 | 2019-2025 | Intellijoint Hip |
| Advita Ortho, LLC | $2,187.50 | 2025 | |
| Medical Device Business Services, INC. | $1,584.50 | 2021-2024 | Velys |
| Stryker Corporation | $953.29 | 2019-2024 | T2 Alpha, Mako |
| Pacira Pharmaceuticals Incorporated | $685.31 | 2019-2023 | Iovera |
| Depuy Synthes Sales INC. | $682.49 | 2019-2024 | Attune, Velys |
| Davol INC. | $464.74 | 2023-2024 | Arista Ah Flexitip |
| Zimmer Biomet Holdings, INC. | $335.38 | 2023-2025 | Mymobility Platform, Rosa |
| Restor3d, INC. | $102.05 | 2023 | |
| Conformis, INC. | $87.95 | 2021 | |
| Encore Medical, LP | $87.25 | 2024 | Djo Surgical |
| Aesculap Implant Systems, LLC | $60.95 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynasplint Systems INC. | $47.90 | 2024 | Dynasplint |
| Solventum Corporation | $32.51 | 2025 | V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta, Prevena |
| Amarin Pharma, INC. | $24.62 | 2019 | |
| Djo, LLC | $17.06 | 2019 | |
| Amgen INC. | $13.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morteza Meftah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.